Emu oil(s): A source of non-toxic transdermal anti-inflammatory agents in aboriginal medicine
- 1 March 1998
- journal article
- research article
- Published by Springer Science and Business Media LLC in Inflammopharmacology
- Vol. 6 (1), 1-8
- https://doi.org/10.1007/s10787-998-0001-9
Abstract
The ‘oil’ obtained from emu fat can be a very effective inhibitor of chronic inflammation in rats when applied dermally (with a skin penetration enhancer). Assays for this activity using the adjuvant-induced arthritis model have shown: i. Considerable variability in potency of some commercial oil samples; ii. Little or no correlation of activity with colour or linolenic acid (18:3) content of the oil; iii. Relative stability of some active oils (to heat, ageing at room temperature); iv. The bulk of the anti-inflammatory activity was present in a low triglyceride fraction; and v. Potential arthritis-suppressant/immunoregulant activity of these active fractions. These studies point to the need for more rigid quality control before considering such a (now proven) traditional medicine as a complementary therapy. Repeated applications of selected oils did not induce any of the more prominent side-effects associated with NSAIDs (e.g. platelet inhibition, gastrotoxicity) or certain anti-arthritic drugs (proteinuria, leukopenia).Keywords
This publication has 5 references indexed in Scilit:
- Anti-inflammatory activity of emu oils in ratsInflammopharmacology, 1997
- Complete prevention of the clinical expression of adjuvant-induced arthritis in rats by cyclosporin-A and lobenzarit: The regulation of lymph node cell populations and cytokine productionInflammation Research, 1996
- Zinc monoglycerolate: A slow-release source of zinc with anti-arthritic activity in ratsInflammation Research, 1990
- Prevention of adjuvant‐induced cachexia in rats by cyclosporin AImmunology & Cell Biology, 1990